Koc B B, Schotanus M G M, Borghans R, Jong B, Maassen M E, Buijsen J, Jansen E J P
Zuyderland Medical Centre, Sittard-Geleen, The Netherlands.
Department of Orthopaedic Surgery and Traumatology, Zuyderland Medical Centre, Dr. H. vd Hoffplein 1, 6162 AG, Sittard-Geleen, The Netherlands.
Eur J Orthop Surg Traumatol. 2019 May;29(4):843-847. doi: 10.1007/s00590-019-02377-8. Epub 2019 Jan 16.
Low-dose radiotherapy (LDRT) for pain reduction in osteoarthritis (OA) is a frequently used treatment in Germany and Eastern European countries. The evidence on the effects of LDRT on pain in patients with OA remains unclear. This study evaluated the effect of LDRT on pain in patients with severe OA of the hip or knee joint.
This prospective study included a total of 16 joints in 12 patients (4 hips and 12 knees). The inclusion criteria were: patients older than 50 years, severe OA (Kellgren-Lawrence grade III-IV) of the hip or knee joint, patients not responding to conservative treatment and patients who are inoperable or not willing to undergo surgery. The joint was irradiated with a total dose of 6.0 Gray. The Numeric Rating Scale for pain (NRS-pain) and patient-reported outcome measures were obtained at pre-, 6, 13, 26, 39 and 52 weeks post-radiation. A decrease of two points on the NRS-pain was defined as clinical relevant.
The median age of the included patients was 74 years (range 58-89). In 50% of the joints (n = 8, 3 hip and 5 knee joints), a clinical relevant difference in pain at 6 weeks post-radiation was observed. This clinical relevant difference decreased to 25% at 52 weeks post-radiation.
LDRT showed a clinical relevant pain relief at 6 weeks after radiotherapy. The long-term effect of LDRT, however, was limited. A randomized placebo-controlled trial is necessary to assess the effect of LDRT on pain in patients with OA of the hip or knee joint.
在德国和东欧国家,低剂量放疗(LDRT)用于减轻骨关节炎(OA)疼痛是一种常用的治疗方法。LDRT对OA患者疼痛影响的证据仍不明确。本研究评估了LDRT对髋或膝关节重度OA患者疼痛的影响。
这项前瞻性研究共纳入12例患者的16个关节(4个髋关节和12个膝关节)。纳入标准为:年龄大于50岁、髋或膝关节重度OA(Kellgren-Lawrence分级III-IV级)、对保守治疗无反应、无法手术或不愿接受手术的患者。关节接受的总辐射剂量为6.0格雷。在放疗前、放疗后6周、13周、26周、39周和52周获取疼痛数字评定量表(NRS-疼痛)和患者报告的结局指标。NRS-疼痛降低2分被定义为具有临床意义。
纳入患者的中位年龄为74岁(范围58-89岁)。在50%的关节(n = 8,3个髋关节和5个膝关节)中,放疗后6周观察到疼痛有临床意义的差异。这种临床意义的差异在放疗后52周降至25%。
LDRT在放疗后6周显示出具有临床意义的疼痛缓解。然而,LDRT的长期效果有限。有必要进行一项随机安慰剂对照试验来评估LDRT对髋或膝关节OA患者疼痛的影响。